The effects of intermittent androgen deprivation therapy (ADT) and zoledronic acid administration on bone density in patients with prostate cancer

被引：0
|
作者：
Katznelson, L. [1 ]
Kent, K. [1 ]
Srinivas, S. [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15593
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer
    Ryan, Christopher W.
    Huo, Dezheng
    Demers, Laurence M.
    Beer, Tomasz M.
    Lacerna, Leo V.
    JOURNAL OF UROLOGY, 2006, 176 (03): : 972 - 978
  • [2] Bone mineral density in prostate cancer patients undergoing initial androgen deprivation therapy: Zoledronic acid vs. placebo
    Israeli, RS
    Rosenberg, S
    Saltzstein, D
    Gottesman, JE
    Goldstein, HB
    Hull, G
    Tran, D
    Warsi, G
    Lacema, LV
    JOURNAL OF UROLOGY, 2006, 175 (04): : 134 - 134
  • [3] The effect of zoledronic acid on bone mineral density in patients undergoing androgen deprivation therapy
    Israeli, Ron S.
    Rosenberg, Steven J.
    Saltzstein, Daniel R.
    Gottesman, James E.
    Goldstein, Howard R.
    Hull, Gerald W.
    Tran, Diep N. H.
    Warsi, Ghulam M.
    Lacerna, Leo V.
    CLINICAL GENITOURINARY CANCER, 2007, 5 (04) : 271 - 277
  • [4] A Review on the Effects of Androgen Deprivation Therapy (ADT) on Bone Health Status in Men with Prostate Cancer
    Mohamad, Nur-Vaizura
    Soelaiman, Ima-Nirwana
    Chin, Kok-Yong
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2017, 17 (04) : 276 - 284
  • [5] Zoledronic acid as adjunct to androgen deprivation therapy reduces bone loss in men with prostate cancer
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 57 - 57
  • [6] Decreases of bone mineral density (BMD) in non-metastatic prostate cancer patients treated with androgen deprivation therapy (ADT)
    Kato, S.
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 : 104 - 104
  • [7] Management of decreased bone mineral density (BMD) in men starting androgen deprivation therapy (ADT) for prostate cancer
    Panju, A. H.
    Breunis, H.
    Cheung, A. M.
    Duff-Canning, S.
    Fleshner, N. E.
    Krahn, M.
    Naglie, G.
    Tomlinson, G.
    Warde, P.
    Alibhai, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Effect of androgen deprivation therapy on bone mineral density in prostate cancer patients
    Deng, JH
    Yang, LP
    Wang, LS
    Zhou, DF
    ASIAN JOURNAL OF ANDROLOGY, 2004, 6 (01) : 75 - 77
  • [9] Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer - Editorial comment
    Saad, Fred
    JOURNAL OF UROLOGY, 2006, 176 (03): : 978 - 978
  • [10] Effect of androgen deprivation therapy on bone mineral density in patients with prostate cancer
    Ilyas, Kashaf
    Hafeez, Zainab
    Latif, Rukhsana
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2022, 38 (05) : 1175 - 1182
12345